Our Science

Our Science

Publications

Year

The Journal of Immunology

September 22, 2022

Cutting Edge: Bispecific γδ T Cell Engager Containing Heterodimeric BTN2A1 and BTN3A1 Promotes Targeted Activation of Vγ9Vδ2+ T Cells in the Presence of Costimulation by CD28 or NKG2D

The Journal of Immunology

July 11, 2022

LIGHT (TNFSF14) Costimulation Enhances Myeloid Cell Activation and Antitumor Immunity in the Setting of PD-1/PD-L1 and TIGIT Checkpoint Blockade

Cancer Immunology Research

December 20, 2019

CD40 Enhances Type I Interferon Responses Downstream of CD47 Blockade, Bridging Innate and Adaptive Immunity

Journal for ImmunoTherapy of Cancer

January 25, 2019

Agonist redirected checkpoint, PD1-Fc-OX40L, for cancer immunotherapy